Dr. Moreau on Tourmaline-MM1 Study for Multiple Myeloma
January 7th 2016
Philippe Moreau, MD, head of Department of Hematology, Centre Hospitalier et Universitaire, Nantes, France, discusses the phase III Tourmaline-MM1 study for patients with relapsed/refractory multiple myeloma.